Spots Global Cancer Trial Database for Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009)
Official Title: Clinical Protocol for the Retrospective Evaluation of a Commercially Available Hydrogel Spacer
Study ID: NCT05423431
Conditions
Interventions
Study Description
Brief Summary: Dosimetry efficacy of the hydrogel spacer.
Detailed Description: Single arm study for evaluation of dosimetry following use of a commercially available hydrogel spacer implanted in up to 20 males who underwent radiotherapy treatment for prostate cancer. Study utilized pre and post gel insertion CT images to determine endpoints.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Advanced Radiation Centers of New York ("ARC"), Lake Success, New York, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
